about
The MUC3 gene encodes a transmembrane mucin and is alternatively splicedTwo novel mucin genes down-regulated in colorectal cancer identified by differential displayExpression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasiaHuman trypsinogen in colorectal cancer.Pressure events surrounding oesophageal acid reflux episodes and acid clearance in ambulant healthy volunteers.Precipitating causes of acid reflux episodes in ambulant patients with gastro-oesophageal reflux disease.Laparoscopic Nissen fundoplication--200 consecutive casesGenomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis.Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus.Current concepts of tumour metastasis.Diffuse oesophageal spasm: diagnosis by ambulatory 24 hour manometry.Identification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma.CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer.Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.New technique for analysing conjugated bile acids in gastric juice.Laparoscopic upper gut surgery.Feasibility of chemoradiation therapy with protracted infusion of 5-fluorouracil for esophageal cancer patients not suitable for cisplatin.Long-term Health-related Quality of Life Following Esophagectomy: A Nonrandomized Comparison of Thoracoscopically Assisted and Open Surgery.Expression of the cell surface mucin gene family in adenocarcinomas.Expression of the CD44v2-10 isoform confers a metastatic phenotype: importance of the heparan sulfate attachment site CD44v3.Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.Captopril inhibits tumour growth in a xenograft model of human renal cell carcinomaSymptomatic and functional outcome after laparoscopic reoperation for failed antireflux surgery.Thoracoscopic-assisted esophagectomy for esophageal cancer: analysis of patterns and prognostic factors for recurrence.Second primary oesophageal cancer following radiation for breast cancer.Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.Positron emission tomography and pathological evidence of response to neoadjuvant therapy in adenocarcinoma of the esophagus.Minimally invasive esophagectomy: short- and long-term outcomes.Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus.Bile acid concentrations in the refluxate of patients with reflux oesophagitis.Factors associated with postoperative pulmonary morbidity after esophagectomy for cancerNeoadjuvant therapy reduces cardiopulmunary function in patients undegoing oesophagectomy.Genome-Wide Copy Number Analysis in Esophageal Adenocarcinoma Using High-Density Single-Nucleotide Polymorphism ArraysA combined modality approach to the management of oesophageal cancerRisk Stratification for Early Esophageal Adenocarcinoma: Analysis of Lymphatic Spread and Prognostic FactorsEvidence that “myofibroblast-like” cells are the cellular source of capsular collage in hepatocellular carcinomaAbdominocervical (transhiatal) oesophagectomy in the management of oesophageal carcinomaThe sphinctometer: a new device for measurement of lower oesophageal sphincter functionBile acids do not modify the effects of pepsin on the fine structure of human oesophageal epitheliumDiffuse esophageal spasm
P50
Q22010259-9976BD97-1F45-4348-9CAF-70B59EB8A0C1Q22010486-C9F11353-D616-4A80-809E-F73F3DA5C8B4Q28248216-ECFFCC44-982F-4E1C-BCAE-1EF1EF34399CQ33949944-74648EFF-6020-45E6-8062-F98F86EA6BDFQ34377157-A817E95F-D27C-4CA6-8821-5CB26849BB7DQ34407782-E4A3F87E-84D9-4737-9A58-95928E72030BQ34409516-CA869DA4-8FCD-4579-A4A7-C1AF076CEF20Q34445264-ED4ABD6A-6D95-49A5-BC4C-18021A839D92Q34691502-93477D80-FEDD-4F21-B657-271932E3A67CQ35138961-E6E3C393-E89D-4D42-A69F-58AC923C7288Q35840966-38A69B22-59EC-4410-A871-5ADE9D6BC232Q36725997-C4F8CACA-BE60-4AA1-8105-B849AA356ED0Q37138668-1B08E615-E6F5-4D9C-B845-770B5A37CFC6Q37229247-A540D3BB-3BF2-493D-89E7-D715CD4ACA16Q37267851-6FEC6FBF-4D3D-4339-B414-454C718AD3F8Q37607346-461305F8-0514-4CA4-91C3-69EAB49CA2FCQ39362540-097928EB-F6DE-4DB4-9412-9C6A9ED2752DQ39590531-3D1F7910-2A0F-4E7E-84C5-DC1BC0C57FC7Q40514404-4B5FE7DD-3D61-42B0-8E94-31DFEFA4F3D0Q40669974-C2467812-432D-4F57-9E38-DFCD5B62C8FAQ41012070-920681C6-AF09-43F1-8F85-63051952380CQ41053553-D7DD0985-0ADE-4B5B-88EF-83B18C08C1C2Q42661555-A0ED2658-2AD6-4C5A-9E1C-342CE3F4D4F9Q42668909-C43F475A-B4CD-48E7-B834-A03E7EFD667FQ43661645-A85CCE41-F78E-4ECA-A0A1-9A7CE2A0A828Q46675470-3186D80C-2D05-40B9-878B-4FBAFC4F004FQ46757993-D7DA1E64-6F78-4C75-A8EB-DB9A3B72AE4FQ47660458-5BAE7BA1-334F-4601-9FDA-757525AA1FBDQ50661717-FECB003E-57A1-46EA-955D-DF83F42F635CQ51625293-648E4202-407D-48D8-901E-007F345FE8C7Q51737547-2D5B9237-4DDA-4A2B-B2A9-AA6D0B170D84Q51738234-7E73A257-BF48-4089-A255-9D14F44BA897Q57742895-98FB021F-DCEF-41ED-A852-53A3727F88B5Q58229292-C400C4AD-572A-4CA6-B7A6-AD77FDDC97BDQ61895891-854DE45B-D1E2-45CD-8377-8AE6785BAAA2Q61895913-076D0057-52C5-4449-9A10-56BA08F646F1Q67666977-3F7D863C-F0DB-4512-930C-2FCEF7686960Q68003099-D2BC7FB7-8762-4649-B542-7AD75B153714Q68164297-2DFD47A4-9A03-4650-B67A-43944C9834BDQ68183349-88B2E4CC-CE29-4364-9D3D-FF2EA64D3031
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-8604-253X
@en
name
David C Gotley
@ast
David C Gotley
@en
David C Gotley
@nl
type
label
David C Gotley
@ast
David C Gotley
@en
David C Gotley
@nl
altLabel
David Gotley
@en
prefLabel
David C Gotley
@ast
David C Gotley
@en
David C Gotley
@nl
P106
P21
P31
P496
0000-0002-8604-253X